Ferrer-Miralles N - Search Results

1

Screening HIV-1 antigenic peptides as receptors for antibodies and CD4 in allosteric nanosensors.

Ferraz RM, Rodríguez-Carmona E, Ferrer-Miralles N, Meyerhans A, Villaverde A. Ferraz RM, et al. J Mol Recognit. 2009 May-Jun;22(3):255-60. doi: 10.1002/jmr.940. J Mol Recognit. 2009. PMID: 19177495

2

Molecular mechanisms for antibody-mediated modulation of peptide-displaying enzyme sensors.

Ferrer-Miralles N, Feliu JX, Villaverde A. Ferrer-Miralles N, et al. Biochem Biophys Res Commun. 2000 Aug 28;275(2):360-4. doi: 10.1006/bbrc.2000.3309. Biochem Biophys Res Commun. 2000. PMID: 10964671

3

Engineering regulable Escherichia coli beta-galactosidases as biosensors for anti-HIV antibody detection in human sera.

Ferrer-Miralles N, Feliu JX, Vandevuer S, Müller A, Cabrera-Crespo J, Ortmans I, Hoffmann F, Cazorla D, Rinas U, Prévost M, Villaverde A. Ferrer-Miralles N, et al. J Biol Chem. 2001 Oct 26;276(43):40087-95. doi: 10.1074/jbc.M104704200. Epub 2001 Jul 30. J Biol Chem. 2001. PMID: 11479300 Free article. Clinical Trial.

4

Enhanced response to antibody binding in engineered beta-galactosidase enzymatic sensors.

Feliu JX, Ferrer-Miralles N, Blanco E, Cazorla D, Sobrino F, Villaverde A. Feliu JX, et al. Biochim Biophys Acta. 2002 Apr 29;1596(2):212-24. doi: 10.1016/s0167-4838(02)00226-1. Biochim Biophys Acta. 2002. PMID: 12007603

5

Engineering of Escherichia coli beta-galactosidase for solvent display of a functional scFv antibody fragment.

Alcalá P, Ferrer-Miralles N, Villaverde A. Alcalá P, et al. FEBS Lett. 2003 Jan 2;533(1-3):115-8. doi: 10.1016/s0014-5793(02)03775-4. FEBS Lett. 2003. PMID: 12505169 Free article.

6

Membrane-active peptides for non-viral gene therapy: making the safest easier.

Ferrer-Miralles N, Vázquez E, Villaverde A. Ferrer-Miralles N, et al. Trends Biotechnol. 2008 May;26(5):267-75. doi: 10.1016/j.tibtech.2008.02.003. Epub 2008 Mar 20. Trends Biotechnol. 2008. PMID: 18358551 Review.

7

Peptide-assisted traffic engineering for nonviral gene therapy.

Vázquez E, Ferrer-Miralles N, Villaverde A. Vázquez E, et al. Drug Discov Today. 2008 Dec;13(23-24):1067-74. doi: 10.1016/j.drudis.2008.08.008. Epub 2008 Oct 1. Drug Discov Today. 2008. PMID: 18801457 Review.

8

Modular protein engineering in emerging cancer therapies.

Vázquez E, Ferrer-Miralles N, Mangues R, Corchero JL, Schwartz S Jr, Villaverde A. Vázquez E, et al. Curr Pharm Des. 2009;15(8):893-916. doi: 10.2174/138161209787582084. Curr Pharm Des. 2009. PMID: 19275653 Review.

9

Microbial factories for recombinant pharmaceuticals.

Ferrer-Miralles N, Domingo-Espín J, Corchero JL, Vázquez E, Villaverde A. Ferrer-Miralles N, et al. Microb Cell Fact. 2009 Mar 24;8:17. doi: 10.1186/1475-2859-8-17. Microb Cell Fact. 2009. PMID: 19317892 Free PMC article.

10

Fast electrochemical detection of anti-HIV antibodies: coupling allosteric enzymes and disk microelectrode arrays.

Laczka O, Ferraz RM, Ferrer-Miralles N, Villaverde A, Muñoz FX, del Campo FJ. Laczka O, et al. Anal Chim Acta. 2009 May 8;641(1-2):1-6. doi: 10.1016/j.aca.2009.03.008. Epub 2009 Mar 17. Anal Chim Acta. 2009. PMID: 19393360 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters